Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma

Masanori Hayashi, Alissa C. Baker, Seth D. Goldstein, Catherine M. Albert, Kyle W. Jackson, Gregory McCarty, Ulf D. Kahlert, David M. Loeb

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The most pressing unmet clinical need for patients with Ewing sarcoma (ES) is the prevention and treatment of metastasis. The Wnt signaling pathway regulates a number of cellular functions associated with metastasis, including proliferation, motility, and stem cell self-renewal. Functional interaction between Wnt ligands and their receptors requires palmitoylation by Porcupine (Porcn), making this an ideal therapeutic target. We studied the effect of WNT974, a potent, selective Porcn inhibitor, on ES metastasis. In vitro, WNT974 does not affect ES proliferation or sarcosphere formation, but suppresses multiple transcriptional regulators of metastasis and inhibits cell migration. In vivo, in an orthotopic implantation/amputation model of spontaneous distant metastasis, single agent WNT974 treatment leads to a significant delay in formation of lung metastasis and a substantial improvement in post-amputation survival without a major effect on primary tumor growth. The drug produces no survival benefit in a tail vein injection model, supporting the hypothesis that WNT974 inhibits early steps in the metastatic cascade, such as migration and invasion. Our findings strongly implicate Wnt signaling in the early steps of ES metastasis and demonstrate that WNT974 has the potential to significantly improve the survival of ES patients through the specific inhibition of metastasis.

Original languageEnglish (US)
Pages (from-to)78265-78276
Number of pages12
JournalOncotarget
Volume8
Issue number45
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Porcupines
Ewing's Sarcoma
Heterografts
Neoplasm Metastasis
Survival
Amputation
Lipoylation
Wnt Signaling Pathway
Cell Movement
Tail
Veins
Therapeutics
Ligands
Lung

Keywords

  • Ewing sarcoma
  • Metastasis
  • Patient-derived xenograft
  • Preclinical model
  • Wnt signaling

ASJC Scopus subject areas

  • Oncology

Cite this

Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma. / Hayashi, Masanori; Baker, Alissa C.; Goldstein, Seth D.; Albert, Catherine M.; Jackson, Kyle W.; McCarty, Gregory; Kahlert, Ulf D.; Loeb, David M.

In: Oncotarget, Vol. 8, No. 45, 01.01.2017, p. 78265-78276.

Research output: Contribution to journalArticle

Hayashi, M, Baker, AC, Goldstein, SD, Albert, CM, Jackson, KW, McCarty, G, Kahlert, UD & Loeb, DM 2017, 'Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma', Oncotarget, vol. 8, no. 45, pp. 78265-78276. https://doi.org/10.18632/oncotarget.19432
Hayashi, Masanori ; Baker, Alissa C. ; Goldstein, Seth D. ; Albert, Catherine M. ; Jackson, Kyle W. ; McCarty, Gregory ; Kahlert, Ulf D. ; Loeb, David M. / Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma. In: Oncotarget. 2017 ; Vol. 8, No. 45. pp. 78265-78276.
@article{27c71421012245a2a6509ccbf8d63206,
title = "Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma",
abstract = "The most pressing unmet clinical need for patients with Ewing sarcoma (ES) is the prevention and treatment of metastasis. The Wnt signaling pathway regulates a number of cellular functions associated with metastasis, including proliferation, motility, and stem cell self-renewal. Functional interaction between Wnt ligands and their receptors requires palmitoylation by Porcupine (Porcn), making this an ideal therapeutic target. We studied the effect of WNT974, a potent, selective Porcn inhibitor, on ES metastasis. In vitro, WNT974 does not affect ES proliferation or sarcosphere formation, but suppresses multiple transcriptional regulators of metastasis and inhibits cell migration. In vivo, in an orthotopic implantation/amputation model of spontaneous distant metastasis, single agent WNT974 treatment leads to a significant delay in formation of lung metastasis and a substantial improvement in post-amputation survival without a major effect on primary tumor growth. The drug produces no survival benefit in a tail vein injection model, supporting the hypothesis that WNT974 inhibits early steps in the metastatic cascade, such as migration and invasion. Our findings strongly implicate Wnt signaling in the early steps of ES metastasis and demonstrate that WNT974 has the potential to significantly improve the survival of ES patients through the specific inhibition of metastasis.",
keywords = "Ewing sarcoma, Metastasis, Patient-derived xenograft, Preclinical model, Wnt signaling",
author = "Masanori Hayashi and Baker, {Alissa C.} and Goldstein, {Seth D.} and Albert, {Catherine M.} and Jackson, {Kyle W.} and Gregory McCarty and Kahlert, {Ulf D.} and Loeb, {David M.}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.19432",
language = "English (US)",
volume = "8",
pages = "78265--78276",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "45",

}

TY - JOUR

T1 - Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma

AU - Hayashi, Masanori

AU - Baker, Alissa C.

AU - Goldstein, Seth D.

AU - Albert, Catherine M.

AU - Jackson, Kyle W.

AU - McCarty, Gregory

AU - Kahlert, Ulf D.

AU - Loeb, David M.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The most pressing unmet clinical need for patients with Ewing sarcoma (ES) is the prevention and treatment of metastasis. The Wnt signaling pathway regulates a number of cellular functions associated with metastasis, including proliferation, motility, and stem cell self-renewal. Functional interaction between Wnt ligands and their receptors requires palmitoylation by Porcupine (Porcn), making this an ideal therapeutic target. We studied the effect of WNT974, a potent, selective Porcn inhibitor, on ES metastasis. In vitro, WNT974 does not affect ES proliferation or sarcosphere formation, but suppresses multiple transcriptional regulators of metastasis and inhibits cell migration. In vivo, in an orthotopic implantation/amputation model of spontaneous distant metastasis, single agent WNT974 treatment leads to a significant delay in formation of lung metastasis and a substantial improvement in post-amputation survival without a major effect on primary tumor growth. The drug produces no survival benefit in a tail vein injection model, supporting the hypothesis that WNT974 inhibits early steps in the metastatic cascade, such as migration and invasion. Our findings strongly implicate Wnt signaling in the early steps of ES metastasis and demonstrate that WNT974 has the potential to significantly improve the survival of ES patients through the specific inhibition of metastasis.

AB - The most pressing unmet clinical need for patients with Ewing sarcoma (ES) is the prevention and treatment of metastasis. The Wnt signaling pathway regulates a number of cellular functions associated with metastasis, including proliferation, motility, and stem cell self-renewal. Functional interaction between Wnt ligands and their receptors requires palmitoylation by Porcupine (Porcn), making this an ideal therapeutic target. We studied the effect of WNT974, a potent, selective Porcn inhibitor, on ES metastasis. In vitro, WNT974 does not affect ES proliferation or sarcosphere formation, but suppresses multiple transcriptional regulators of metastasis and inhibits cell migration. In vivo, in an orthotopic implantation/amputation model of spontaneous distant metastasis, single agent WNT974 treatment leads to a significant delay in formation of lung metastasis and a substantial improvement in post-amputation survival without a major effect on primary tumor growth. The drug produces no survival benefit in a tail vein injection model, supporting the hypothesis that WNT974 inhibits early steps in the metastatic cascade, such as migration and invasion. Our findings strongly implicate Wnt signaling in the early steps of ES metastasis and demonstrate that WNT974 has the potential to significantly improve the survival of ES patients through the specific inhibition of metastasis.

KW - Ewing sarcoma

KW - Metastasis

KW - Patient-derived xenograft

KW - Preclinical model

KW - Wnt signaling

UR - http://www.scopus.com/inward/record.url?scp=85030465392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030465392&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.19432

DO - 10.18632/oncotarget.19432

M3 - Article

AN - SCOPUS:85030465392

VL - 8

SP - 78265

EP - 78276

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 45

ER -